Spotlight
Dec 15, 2025

BREAKING: FDA Launches Investigation Into COVID-Era D*aths

The Food and Drug Administration has launched a sweeping new investigation into whether COVID‑19 vaccines may be linked to deaths across multiple age groups, including adults and children, marking a dramatic shift in federal vaccine oversight.

 

This probe follows the circulation of an internal November memo from Dr. Vinay Prasad, the FDA’s lead vaccine regulator, that directly informed agency staff that about 10 children’s deaths were linked to COVID‑19 shots after initial analysis of reported fatalities.

According to a Department of Health and Human Services spokesman, Andrew Nixon, the investigation will be “thorough” and examine the safety of the COVID‑19 vaccines across all age groups—not just those under 18—reflecting growing concern about vaccine safety.

Prasad’s memo revealed that the FDA had examined roughly 96 deaths reported to the Vaccine Adverse Event Reporting System (VAERS) and determined at least 10 could be related to COVID‑19 vaccination, a conclusion many observers say demands transparency and accountability.

The memo stated in blunt terms that “healthy young children who faced tremendously low risk of death were coerced, at the behest of the Biden administration, via school and work mandates, to receive a vaccine that could result in death,” laying blame on federal policy rather than parental choice.

The memo quoted CNN when characterizing the serious concern that vaccines were being administered to children who faced minimal risk from COVID‑19 itself, especially given what Prasad described as comparisons to typical respiratory viruses.

No details have been publicly released regarding the identities of the deceased, including which vaccine manufacturers were involved, the ages of the children, or whether preexisting conditions played a role, leaving crucial questions unanswered.

Prasad’s internal communication also revealed that as a direct result of these troubling findings, the FDA plans to overhaul its vaccine approval process, requiring significantly more evidence of safety and efficacy before new vaccines can be marketed to the public.

In a historic move earlier this fall, the Centers for Disease Control and Prevention updated its immunization schedule to remove the COVID‑19 vaccine as a recommended shot, shifting toward “individual‑based decision making” for adults and children alike.

This policy change was adopted to align with recommendations from the CDC’s Advisory Committee on Immunization Practices, and it reflects growing acknowledgement within federal public health agencies that the blanket COVID‑19 vaccine mandate approach may not be sustainable or appropriate.

In the wake of the memo, twelve former FDA commissioners published a response in the New England Journal of Medicine criticizing the agency’s new stance and warning that dramatic shifts in vaccine policy could “undermine the public interest.”

Other posts